Ticker
BOLTCompany Name
BOLT BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -51.36M | -1232.49% | $ 4.17M |
3/31/2025 | $ -57.9M | -1591.62% | $ 3.64M |
12/31/2024 | $ -61.29M | -797% | $ 7.69M |
9/30/2024 | $ -61.12M | -625.05% | $ 9.78M |
6/30/2024 | $ -63.91M | -572.34% | $ 11.17M |
3/31/2024 | $ -62.88M | -555.25% | $ 11.32M |
12/31/2023 | $ -69.53M | -882.75% | $ 7.88M |
9/30/2023 | $ -73.21M | -1017.12% | $ 7.2M |
6/30/2023 | $ -69.91M | -1030.88% | $ 6.78M |
3/31/2023 | $ -75.59M | -1121.17% | $ 6.74M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for BOLT BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -47.31M ] / Revenues [ $ 231K ]
(=) OCF % [ -20479.65% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |